Skip to main content
Clinical Trials/CTRI/2021/02/031445
CTRI/2021/02/031445Completed未知

Analysing the effectiveness of anti H pylori therapy in patients with non-ulcer dyspepsia diagnosed by Rome IV criteria and having H pylori positive status

Dr VIVEK BHAVANAM0 sites73 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
73

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Rome IV Criteria
  • One or more of the following:
  • 1. Bothersome postprandial fullness
  • 2. Bothersome early satiation
  • 3. Bothersome epigastric pain
  • 4. Bothersome epigastric burning
  • No evidence of structural disease(including at upper GI endoscopy) that is likely to explain the symptoms.
  • Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis.

Exclusion Criteria

  • 1. Any evidence of organic (pancreatobiliary disease, oesophagitis, peptic ulcer disease and neoplastic disease), drug-induced (non steroidal anti-inflammatory drugs), endocrine and metabolic disorders diagnosed by appropriate investigations.
  • 2. Symptoms that are relieved by evacuation of feces or gas
  • 3. Persistent vomiting
  • 4. Biliary pain
  • 5. Any erosion/ulcer in upper GI endoscopy
  • 6. Pregnant women

Investigators

Sponsor
Dr VIVEK BHAVANAM

Similar Trials